These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 35774851)
1. Identification of Five N6-Methylandenosine-Related ncRNA Signatures to Predict the Overall Survival of Patients with Gastric Cancer. Yue Q; Zhang Y; Bai J; Duan X; Wang H Dis Markers; 2022; 2022():7765900. PubMed ID: 35774851 [TBL] [Abstract][Full Text] [Related]
2. N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patients. Xu S; Chen W; Wang Y; Zhang Y; Xia R; Shen J; Gong X; Liang Y; Xu J; Tang H; Zhao T; Zhang Y; Chen T; Wang C BMC Cancer; 2022 Jul; 22(1):721. PubMed ID: 35778697 [TBL] [Abstract][Full Text] [Related]
3. N6-methyladenosine-related non-coding RNAs are potential prognostic and immunotherapeutic responsiveness biomarkers for bladder cancer. Lu M; Zhan H; Liu B; Li D; Li W; Chen X; Zhou X EPMA J; 2021 Dec; 12(4):589-604. PubMed ID: 34950253 [TBL] [Abstract][Full Text] [Related]
4. Identification of a novel m6A-related lncRNA pair signature for predicting the prognosis of gastric cancer patients. Wang JM; Li X; Yang P; Geng WB; Wang XY BMC Gastroenterol; 2022 Feb; 22(1):76. PubMed ID: 35189810 [TBL] [Abstract][Full Text] [Related]
5. N6-methylandenosine-related lncRNAs play an important role in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma. Hu Y; Chen Y Sci Rep; 2021 Sep; 11(1):17844. PubMed ID: 34497315 [TBL] [Abstract][Full Text] [Related]
6. N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma. Yang K; Wang F; Li K; Peng G; Yang H; Xu H; Xiang Y; Sun H Technol Cancer Res Treat; 2022; 21():15330338221085354. PubMed ID: 35422168 [No Abstract] [Full Text] [Related]
7. Analysis of N6-methyladenosine-related lncRNAs in the tumor immune microenvironment and their prognostic role in pancreatic cancer. Liu Y; Wang T; Fang Z; Kong J; Liu J J Cancer Res Clin Oncol; 2022 Jul; 148(7):1613-1626. PubMed ID: 35314871 [TBL] [Abstract][Full Text] [Related]
8. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer. Song Y; Qu H BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619 [TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer. Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183 [TBL] [Abstract][Full Text] [Related]
10. Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma. Yuan Q; Ren J; Li L; Li S; Xiang K; Shang D Bioengineered; 2021 Dec; 12(1):2432-2448. PubMed ID: 34233576 [TBL] [Abstract][Full Text] [Related]
11. Identification of Prognostic Markers of N6-Methylandenosine-Related Noncoding RNAs in Non-Small-Cell Lung Cancer. Zhang Z; Li J; Lu K; Wu W; Huang Z; Zhang C; Guo W; Li J; Lin L J Oncol; 2022; 2022():3657349. PubMed ID: 35401751 [TBL] [Abstract][Full Text] [Related]
12. Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma. Zhao J; Lin X; Zhuang J; He F Front Genet; 2021; 12():714697. PubMed ID: 34777460 [No Abstract] [Full Text] [Related]
13. Comprehensive Analysis of N6-Methyladenosine-Related lncRNA Signature for Predicting Prognosis and Immune Cell Infiltration in Patients with Colorectal Cancer. Zhao Z; Yang YB; Li XY; Li XG; Chu XD; Lin ZB; Zhang YR; Guo YG; Ding H; Pan YL; Wang L; Pan JH Dis Markers; 2021; 2021():8686307. PubMed ID: 34745388 [TBL] [Abstract][Full Text] [Related]
14. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients. Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357 [TBL] [Abstract][Full Text] [Related]
15. Construction of a Novel Signature and Prediction of the Immune Landscape in Soft Tissue Sarcomas Based on N6-Methylandenosine-Related LncRNAs. Zhang L; Tang X; Wan J; Zhang X; Zheng T; Lin Z; Liu T Front Mol Biosci; 2021; 8():715764. PubMed ID: 34733885 [No Abstract] [Full Text] [Related]
16. A ten N6-methyladenosine-related long non-coding RNAs signature predicts prognosis of triple-negative breast cancer. Wu J; Cai Y; Zhao G; Li M J Clin Lab Anal; 2021 Jun; 35(6):e23779. PubMed ID: 33934391 [TBL] [Abstract][Full Text] [Related]
17. Integrated analysis on the N6-methyladenosine-related long noncoding RNAs prognostic signature, immune checkpoints, and immune cell infiltration in clear cell renal cell carcinoma. Qiu Y; Wang X; Fan Z; Zhan S; Jiang X; Huang J Immun Inflamm Dis; 2021 Dec; 9(4):1596-1612. PubMed ID: 34432955 [TBL] [Abstract][Full Text] [Related]
18. Integrated risk scores from N6-methyladenosine-related lncRNAs are potential biomarkers for predicting the overall survival of bladder cancer patients. Huang X; Wang HF; Huang S Front Genet; 2022; 13():906880. PubMed ID: 36061188 [No Abstract] [Full Text] [Related]
19. An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancer. Ma T; Wang X; Meng L; Liu X; Wang J; Zhang W; Tian Z; Zhang Y BMC Cancer; 2021 Nov; 21(1):1256. PubMed ID: 34802433 [TBL] [Abstract][Full Text] [Related]
20. Integrated Analyses Reveal Potential Functional N6-Methyladenosine-Related Long Noncoding RNAs in Adrenocortical Adenocarcinoma. Ding Y; Wang T; Feng Y; Ding X; Li X; Huang Z; Jia Z; Wang J; Yang J Front Cell Dev Biol; 2022; 10():851748. PubMed ID: 35669515 [No Abstract] [Full Text] [Related] [Next] [New Search]